1. Andrews S, Holden R (2012) Characteristics and management of immunerelated adverse effects associated with ipilimumab, a new immunotherapy for metastatic melanoma. Cancer Manag Res 4:299–307
2. Dieng M, Kasparian NA, Mireskandari S, Butow P, Costa D, Morton R, Mann G, Menzies S, Cust A (2017) Psychoeducational intervention for people at high risk of developing another melanoma: a pilot randomised controlled trial. BMJ Open 7(10):e015195
3. Australian Institute of Health and Welfare Australian Cancer Incidence and Mortality (ACIM) books: melanoma of the skin, AIHW, Editor. 2017: Canberra
4. Kimbrough CW, McMasters KM, Davis EG (2014) Principles of surgical treatment of malignant melanoma. Surg Clin 94(5):973–988
5. Mahadevan A, Patel VL, Dagoglu N (2015) Radiation therapy in the management of malignant melanoma. Oncology (Williston Park) 29(10):743–751